Wealth Effects LLC lowered its stake in Enovix Co. (NASDAQ:ENVX – Free Report) by 4.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 234,501 shares of the company’s stock after selling 11,000 shares during the period. Enovix makes up 0.9% of Wealth Effects LLC’s investment portfolio, making the stock its 18th biggest position. Wealth Effects LLC’s holdings in Enovix were worth $2,549,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Fifth Third Bancorp boosted its position in Enovix by 66.7% during the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock worth $27,000 after buying an additional 1,000 shares during the period. Strategic Investment Solutions Inc. IL bought a new stake in shares of Enovix in the second quarter worth $39,000. Prospera Private Wealth LLC acquired a new stake in Enovix in the third quarter valued at $27,000. Voisard Asset Management Group Inc. raised its position in Enovix by 40.0% during the 3rd quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock worth $65,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Quest Partners LLC lifted its holdings in Enovix by 318.5% during the 3rd quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock worth $77,000 after buying an additional 6,294 shares during the period. Institutional investors own 50.92% of the company’s stock.
Insider Buying and Selling at Enovix
In related news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the transaction, the director now owns 99,497 shares of the company’s stock, valued at $968,105.81. The trade was a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 15.70% of the company’s stock.
Enovix Price Performance
Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.03. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. The business had revenue of $4.30 million during the quarter, compared to the consensus estimate of $4.11 million. During the same quarter last year, the firm posted ($0.27) EPS. Equities research analysts forecast that Enovix Co. will post -1.17 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on ENVX shares. Janney Montgomery Scott downgraded Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a research report on Thursday, October 31st. Benchmark restated a “buy” rating and issued a $25.00 price target on shares of Enovix in a research report on Wednesday, October 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $20.50.
Get Our Latest Stock Report on Enovix
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Articles
- Five stocks we like better than Enovix
- How to Invest in Biotech Stocks
- What Does the Future Hold for Eli Lilly?
- ESG Stocks, What Investors Should Know
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- How to Invest in Small Cap Stocks
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.